These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23796873)

  • 1. TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients.
    Malhotra S; Castilló J; Negrotto L; Merino-Zamorano C; Montaner J; Vidal-Jordana A; Montalban X; Comabella M
    J Neuroimmunol; 2013 Aug; 261(1-2):146-8. PubMed ID: 23796873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
    J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis of histamine receptors in peripheral blood mononuclear cells from individuals with clinically-isolated syndrome and different stages of multiple sclerosis.
    Costanza M; Di Dario M; Steinman L; Farina C; Pedotti R
    J Neuroimmunol; 2014 Dec; 277(1-2):186-8. PubMed ID: 25293806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IL-2, IFN-gamma, and TNF-alpha mRNA expression in peripheral blood mononuclear cells in patients with multiple sclerosis].
    Lin J; Li L; Gao Y; Min B; Xu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Feb; 19(1):24-8. PubMed ID: 10453548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP
    Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17A and interleukin-17F mRNA expression in peripheral blood mononuclear cells of patients with multiple sclerosis.
    Babaloo Z; Babaie F; Farhoodi M; Aliparasti MR; Baradaran B; Almasi S; Hoseini A
    Iran J Immunol; 2010 Dec; 7(4):202-9. PubMed ID: 21189442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory nuclear receptor superfamily in multiple sclerosis patients from Sardinia and Sweden.
    Liu X; Steffensen KR; Sanna A; Arru G; Fois ML; Rosati G; Sotgiu S; Link H; Gustafsson JA; Huang YM
    Neurobiol Dis; 2005 Dec; 20(3):961-8. PubMed ID: 16023861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Deficient mRNA expression of specific protein 3 gene in peripheral blood mononuclear cells from patients with multiple sclerosis].
    Lin AY; Yang QD; Murong SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):187-9. PubMed ID: 18393243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.
    Rieckmann P; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Helwig A; Poser S
    Ann Neurol; 1995 Jan; 37(1):82-8. PubMed ID: 7818262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis.
    Tham E; Gielen AW; Khademi M; Martin C; Piehl F
    Scand J Immunol; 2006 Dec; 64(6):609-22. PubMed ID: 17083617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?
    Brynedal B; Khademi M; Wallström E; Hillert J; Olsson T; Duvefelt K
    Neurobiol Dis; 2010 Mar; 37(3):613-21. PubMed ID: 19944761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A.
    Sarchielli P; Critelli A; Greco L; Sokola E; Floridi A; Gallai V
    Cytokine; 2001 Jun; 14(5):294-8. PubMed ID: 11444910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
    Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
    J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Farhum F; Karni A
    J Neurol Sci; 2010 Aug; 295(1-2):31-7. PubMed ID: 20541775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant stress-induced Hsp70 expression in immune cells in multiple sclerosis.
    Cwiklinska H; Mycko MP; Szymanska B; Matysiak M; Selmaj KW
    J Neurosci Res; 2010 Nov; 88(14):3102-10. PubMed ID: 20806409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients.
    Infante-Duarte C; Weber A; Krätzschmar J; Prozorovski T; Pikol S; Hamann I; Bellmann-Strobl J; Aktas O; Dörr J; Wuerfel J; Stürzebecher CS; Zipp F
    FASEB J; 2005 Nov; 19(13):1902-4. PubMed ID: 16144955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
    Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
    J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis.
    Gandhi KS; McKay FC; Cox M; Riveros C; Armstrong N; Heard RN; Vucic S; Williams DW; Stankovich J; Brown M; Danoy P; Stewart GJ; Broadley S; Moscato P; Lechner-Scott J; Scott RJ; Booth DR;
    Hum Mol Genet; 2010 Jun; 19(11):2134-43. PubMed ID: 20190274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of K2P5.1 potassium channels in multiple sclerosis.
    Bittner S; Bobak N; Herrmann AM; Göbel K; Meuth P; Höhn KG; Stenner MP; Budde T; Wiendl H; Meuth SG
    Ann Neurol; 2010 Jul; 68(1):58-69. PubMed ID: 20582984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MICB gene expression on peripheral blood mononuclear cells and susceptibility to multiple sclerosis in north of Iran.
    Abediankenari S; Yousefzadeh Y; Majidi M; Ghasemi M; Nasehi MM; Ghaffari J; Habibi Saravi R; Abedini M; Elyasi M
    Iran J Allergy Asthma Immunol; 2011 Dec; 10(4):261-5. PubMed ID: 22184268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.